OSI Pharmaceuticals
OSI Pharmaceuticals (United States) has no DMF, CEP or site registration linked in our records. 2 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “OSI Pharmaceuticals: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/osi-pharmaceuticals
Overview
OSI Pharmaceuticals is a biotechnology company focused on developing and commercializing oncology therapies. It is a subsidiary of Astellas Pharma.
Therapeutic areas
FDA compliance signals
2 FDA enforcement records linked to this company.
- 4832010-09-22
Late submission of 15-day report
- 4832010-09-22
Submission of report follow-up
Is this OSI Pharmaceuticals?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.